Listed

Amphastar Pharmaceuticals, Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Mar 15, 2016 and accepted by EDGAR at Mar 15, 2016, 14:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-10-01 to 2015-12-31$76.9mus-gaap:SalesRevenueNet
Revenue12 months2015-01-01 to 2015-12-31$251.5mus-gaap:SalesRevenueNet
Cost of revenue12 months2015-01-01 to 2015-12-31$174.2mus-gaap:CostOfRevenue
Gross profit3 months2015-10-01 to 2015-12-31$33.2mus-gaap:GrossProfit
Gross profit12 months2015-01-01 to 2015-12-31$77.3mus-gaap:GrossProfit
Research and development12 months2015-01-01 to 2015-12-31$37.1mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2015-01-01 to 2015-12-31−$6.9mus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31$987.0kus-gaap:InterestExpense
Income tax12 months2015-01-01 to 2015-12-31−$7.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-10-01 to 2015-12-31$7.5mus-gaap:NetIncomeLoss
Net income12 months2015-01-01 to 2015-12-31−$2.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-10-01 to 2015-12-31$0.16us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31−$0.06us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-10-01 to 2015-12-31$0.17us-gaap:EarningsPerShareBasic
Basic EPS12 months2015-01-01 to 2015-12-31−$0.06us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-10-01 to 2015-12-3146,709 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)12 months2015-01-01 to 2015-12-3144,961,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2015-01-01 to 2015-12-31$14.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2015-01-01 to 2015-12-31$9.9mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-12-31$66.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$175.9mus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$390.1mus-gaap:Assets
Current liabilitiesAt period end2015-12-31$60.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-12-31$94.6mus-gaap:Liabilities
Long-term debtAt period end2015-12-31$40.3mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2015-12-31$295.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001558370-16-004146. Last ingested by Listed: Nov 6, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.